These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 19540595)

  • 1. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
    Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
    Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Martinez RL; Alkan S
    Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
    Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
    Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and function of TRAF1 in Hodgkin's lymphoma cells.].
    Wang WJ; Guo F; Sun AN; Zhou P; Ma L
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):29-33. PubMed ID: 20302775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.
    Yamamoto H; Kishimoto T; Minamoto S
    J Immunol; 1998 Nov; 161(9):4753-9. PubMed ID: 9794406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 ligation induces nuclear factor-kappa B activation in human T cell lines.
    McDonald PP; Cassatella MA; Bald A; Maggi E; Romagnani S; Gruss HJ; Pizzolo G
    Eur J Immunol; 1995 Oct; 25(10):2870-6. PubMed ID: 7589085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of constitutive NF-kappaB and JNK signaling by PKN1-mediated phosphorylation of TRAF1.
    Kato T; Gotoh Y; Hoffmann A; Ono Y
    Genes Cells; 2008 May; 13(5):509-20. PubMed ID: 18429822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
    Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
    Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF receptor-associated factor 1 is a positive regulator of the NF-kappaB alternative pathway.
    Lavorgna A; De Filippi R; Formisano S; Leonardi A
    Mol Immunol; 2009 Oct; 46(16):3278-82. PubMed ID: 19698991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
    Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling.
    Wicovsky A; Salzmann S; Roos C; Ehrenschwender M; Rosenthal T; Siegmund D; Henkler F; Gohlke F; Kneitz C; Wajant H
    Cell Death Differ; 2009 Nov; 16(11):1445-59. PubMed ID: 19557010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
    Bargou RC; Emmerich F; Krappmann D; Bommert K; Mapara MY; Arnold W; Royer HD; Grinstein E; Greiner A; Scheidereit C; Dörken B
    J Clin Invest; 1997 Dec; 100(12):2961-9. PubMed ID: 9399941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation.
    Higuchi M; Matsuda T; Mori N; Yamada Y; Horie R; Watanabe T; Takahashi M; Oie M; Fujii M
    Retrovirology; 2005 May; 2():29. PubMed ID: 15876358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.